UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neuropathology in an α-synuclein preformed fibril mouse model occurs independent of the Parkinson's disease-linked lysosomal ATP13A2 protein

Neurobiology of disease, 2024-11, Vol.202, p.106701, Article 106701

2024

Volltextzugriff (PDF)

Bidirectional interaction between IL and 17A/IL-17RA pathway dysregulation and α-synuclein in the pathogenesis of Parkinson’s disease

Brain, behavior, and immunity, 2024-10

2024

Volltextzugriff (PDF)

The role of polo‐like kinases 2 in the proteasomal and lysosomal degradation of alpha‐synuclein in neurons

The FASEB journal, 2024-10, Vol.38 (20), p.e70121-n/a

2024

Volltextzugriff (PDF)

Deficiency of parkin causes neurodegeneration and accumulation of pathological α-synuclein in monkey models

The Journal of clinical investigation, 2024-10, Vol.134 (20), p.1-19

2024

Volltextzugriff (PDF)

α-Synuclein disrupts microglial autophagy through STAT1-dependent suppression of Ulk1 transcription

Journal of neuroinflammation, 2024-10, Vol.21 (1), p.275-19, Article 275

2024

Volltextzugriff (PDF)

Hypothesis-based investigation of known AD risk variants reveals the genetic underpinnings of neuropathological lesions observed in Alzheimer’s-type dementia

Acta neuropathologica, 2024-10, Vol.148 (1), p.55, Article 55

2024

Volltextzugriff (PDF)

Measurement of α-synuclein as protein cargo in plasma extracellular vesicles

Proceedings of the National Academy of Sciences - PNAS, 2024-11, Vol.121 (45), p.e2408949121

2024

Volltextzugriff (PDF)

Amyloid accelerator polyphosphate fits as the mystery density in α-synuclein fibrils

PLoS biology, 2024-10, Vol.22 (10), p.e3002650

2024

Volltextzugriff (PDF)

TREM2 signaling in Parkinson’s disease: Regulation of microglial function and α-synuclein pathology

International immunopharmacology, 2024-12, Vol.143 (Pt 2), p.113446, Article 113446

2024

Volltextzugriff (PDF)

Microglial Melatonin Receptor 1 Degrades Pathological Alpha‐Synuclein Through Activating LC3‐Associated Phagocytosis In Vitro

CNS neuroscience & therapeutics, 2024-10, Vol.30 (10), p.e70088-n/a

2024

Volltextzugriff (PDF)

A minimally invasive biomarker for sensitive and accurate diagnosis of Parkinson's disease

Acta neuropathologica communications, 2024-10, Vol.12 (1), p.167-12, Article 167

2024

Volltextzugriff (PDF)

Differentially heterogeneous hydration environment of the familial mutants of α-synuclein

The Journal of chemical physics, 2024-10, Vol.161 (15)

2024

Volltextzugriff (PDF)

The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson’s disease

Frontiers in pharmacology, 2024-10, Vol.15

2024

Volltextzugriff (PDF)

Imaging flow cytometry reveals LPS-induced changes to intracellular intensity and distribution of α-synuclein in a TLR4-dependent manner in STC-1 cells

Methods (San Diego, Calif.), 2024-10

2024

Volltextzugriff (PDF)

RNA G-quadruplexes form scaffolds that promote neuropathological α-synuclein aggregation

Cell, 2024-10

2024

Volltextzugriff (PDF)

Mechanistic insights into the neurotoxicity of F53B: Effects on metabolic dysregulation and apoptosis of dopaminergic neurons

Journal of hazardous materials, 2024-10, Vol.480, p.136306, Article 136306

2024

Volltextzugriff (PDF)

From Organotypic Mouse Brain Slices to Human Alzheimer's Plasma Biomarkers: A Focus on Nerve Fiber Outgrowth

Biomolecules (Basel, Switzerland), 2024-10, Vol.14 (10), p.1326

2024

Volltextzugriff (PDF)

NEUROINFLAMMATION IN PARKINSON’S DISEASE: A STUDY WITH [11C]PBR28 PET AND CEREBROSPINAL FLUID MARKERS

Parkinsonism & related disorders, 2024-10, p.107177, Article 107177

2024

Volltextzugriff (PDF)

Circadian rhythm disruption: a potential trigger in Parkinson’s disease pathogenesis

Frontiers in cellular neuroscience, 2024-10, Vol.18

2024

Volltextzugriff (PDF)

α-Synuclein aggregation decreases cortico-amygdala connectivity and impairs social behavior in mice

Neurobiology of disease, 2024-11, Vol.202, p.106702, Article 106702

2024

Volltextzugriff (PDF)

Editorial: Celebrating women's contribution to protein folding, misfolding, and degradation in honor of Susan Lindquist (1949-2016)

Frontiers in molecular biosciences, 2024-10, Vol.11, p.1504059

2024

Volltextzugriff (PDF)

Binding of α-synuclein to ACO2 promotes progressive mitochondrial dysfunction in Parkinson's disease models

Redox biology, 2024-11, Vol.77, p.103399, Article 103399

2024

Volltextzugriff (PDF)

Liquid–liquid phase separation and conformational strains of α-Synuclein: implications for Parkinson’s disease pathogenesis

Frontiers in molecular neuroscience, 2024-10, Vol.17

2024

Volltextzugriff (PDF)

A new immunofluorescence determination of Parkinson's disease biomarkers using silver nanoparticles

Alexandria engineering journal, 2025-01, Vol.111, p.404-414

2025

Volltextzugriff (PDF)

Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy

Behavioral and brain functions, 2024-11, Vol.20 (1), p.28-16, Article 28

2024

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

Neu hinzugefügt... seit 30 Tagen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(39)
Tagungsberichte
(1)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Neuropathology in an α-synuclein preformed fibril mouse model occurs independent of the Parkinson's disease-linked lysosomal ATP13A2 protein

Bidirectional interaction between IL and 17A/IL-17RA pathway dysregulation and α-synuclein in the pathogenesis of Parkinson’s disease

The role of polo‐like kinases 2 in the proteasomal and lysosomal degradation of alpha‐synuclein in neurons

Deficiency of parkin causes neurodegeneration and accumulation of pathological α-synuclein in monkey models

α-Synuclein disrupts microglial autophagy through STAT1-dependent suppression of Ulk1 transcription

Hypothesis-based investigation of known AD risk variants reveals the genetic underpinnings of neuropathological lesions observed in Alzheimer’s-type dementia

Measurement of α-synuclein as protein cargo in plasma extracellular vesicles

Amyloid accelerator polyphosphate fits as the mystery density in α-synuclein fibrils

TREM2 signaling in Parkinson’s disease: Regulation of microglial function and α-synuclein pathology

Microglial Melatonin Receptor 1 Degrades Pathological Alpha‐Synuclein Through Activating LC3‐Associated Phagocytosis In Vitro

A minimally invasive biomarker for sensitive and accurate diagnosis of Parkinson's disease

Differentially heterogeneous hydration environment of the familial mutants of α-synuclein

The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson’s disease

Imaging flow cytometry reveals LPS-induced changes to intracellular intensity and distribution of α-synuclein in a TLR4-dependent manner in STC-1 cells

RNA G-quadruplexes form scaffolds that promote neuropathological α-synuclein aggregation

Mechanistic insights into the neurotoxicity of F53B: Effects on metabolic dysregulation and apoptosis of dopaminergic neurons

From Organotypic Mouse Brain Slices to Human Alzheimer's Plasma Biomarkers: A Focus on Nerve Fiber Outgrowth

NEUROINFLAMMATION IN PARKINSON’S DISEASE: A STUDY WITH [11C]PBR28 PET AND CEREBROSPINAL FLUID MARKERS

Circadian rhythm disruption: a potential trigger in Parkinson’s disease pathogenesis

α-Synuclein aggregation decreases cortico-amygdala connectivity and impairs social behavior in mice

Editorial: Celebrating women's contribution to protein folding, misfolding, and degradation in honor of Susan Lindquist (1949-2016)

Binding of α-synuclein to ACO2 promotes progressive mitochondrial dysfunction in Parkinson's disease models

Liquid–liquid phase separation and conformational strains of α-Synuclein: implications for Parkinson’s disease pathogenesis

A new immunofluorescence determination of Parkinson's disease biomarkers using silver nanoparticles

Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy

Aktive Filter

Suchergebnisse filtern